In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Doximity Inc (NYSE: DOCS) closed at $74.4 in the last session, up 0.03% from day before closing price of $74.38. In other words, the price has increased by $0.03 from its previous closing price. On the day, 1.23 million shares were traded. DOCS stock price reached its highest trading level at $75.75 during the session, while it also had its lowest trading level at $73.93.
Ratios:
We take a closer look at DOCS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.50. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On June 02, 2025, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $80.
Piper Sandler Upgraded its Neutral to Overweight on February 07, 2025, whereas the target price for the stock was revised from $31 to $78.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 24 ’25 when Cabral Timothy S sold 20,000 shares for $75.00 per share. The transaction valued at 1,500,000 led to the insider holds 3,221 shares of the business.
TIMOTHY CABRAL bought 20,000 shares of DOCS for $1,500,000 on Sep 24 ’25. On Sep 12 ’25, another insider, Benjamin Regina M., who serves as the Director of the company, sold 5,000 shares for $70.50 each. As a result, the insider received 352,500 and left with 19,839 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 13935079424 and an Enterprise Value of 13105947648. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.87, and their Forward P/E ratio for the next fiscal year is 44.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.64 while its Price-to-Book (P/B) ratio in mrq is 13.60. Its current Enterprise Value per Revenue stands at 22.227 whereas that against EBITDA is 53.734.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.38, which has changed by 0.707597 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $40.87. The 50-Day Moving Average of the stock is 13.01%, while the 200-Day Moving Average is calculated to be 22.50%.
Shares Statistics:
According to the various share statistics, DOCS traded on average about 1.63M shares per day over the past 3-months and 1607700 shares per day over the past 10 days. A total of 136.53M shares are outstanding, with a floating share count of 132.40M. Insiders hold about 29.32% of the company’s shares, while institutions hold 65.71% stake in the company. Shares short for DOCS as of 1757894400 were 4823111 with a Short Ratio of 2.97, compared to 1755216000 on 4360055. Therefore, it implies a Short% of Shares Outstanding of 4823111 and a Short% of Float of 3.6199997999999995.
Earnings Estimates
The dynamic stock of Doximity Inc (DOCS) is currently attracting attention from 16.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.45, with high estimates of $0.49 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.35 for the fiscal current year, implying an average EPS of $1.51. EPS for the following year is $1.67, with 17.0 analysts recommending between $1.89 and $1.47.
Revenue Estimates
According to 17 analysts, . The current quarter’s revenue is expected to be $157.27M. It ranges from a high estimate of $158M to a low estimate of $152.7M. As of . The current estimate, Doximity Inc’s year-ago sales were $136.83MFor the next quarter, 17 analysts are estimating revenue of $180.09M. There is a high estimate of $183.9M for the next quarter, whereas the lowest estimate is $170.24M.
A total of 19 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $640M, while the lowest revenue estimate was $625M, resulting in an average revenue estimate of $633.78M. In the same quarter a year ago, actual revenue was $570.4MBased on 19 analysts’ estimates, the company’s revenue will be $702.92M in the next fiscal year. The high estimate is $721.4M and the low estimate is $688.37M.
